Enorama Pharma AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-75.14	-43.81	-44.61	-42.03	-27.74	Upgrade
Depreciation & Amortization	0.47	0.44	0.68	0.67	0.66	Upgrade
Other Amortization	-	2.87	2.87	2.87	0.72	Upgrade
Asset Writedown & Restructuring Costs	-	17.1	-	-	-	Upgrade
Other Operating Activities	16.57	-	-	-	-	Upgrade
Change in Accounts Receivable	-1.41	0.72	2.26	4.2	-2.6	Upgrade
Change in Inventory	-6.12	-6.98	-1.46	-1.6	0.48	Upgrade
Change in Other Net Operating Assets	6.36	-6.04	-1.09	2.94	-1.68	Upgrade
Operating Cash Flow	-59.26	-35.7	-41.35	-32.96	-30.16	Upgrade
Capital Expenditures	-	-	-	-	-0.06	Upgrade
Sale (Purchase) of Intangibles	-	-	-	-	-1.76	Upgrade
Investing Cash Flow	-	-	-	-	-1.82	Upgrade
Long-Term Debt Issued	20.13	-	2.2	20	8	Upgrade
Long-Term Debt Repaid	-	-0.44	-3.46	-2.09	-9.92	Upgrade
Net Debt Issued (Repaid)	20.13	-0.44	-1.26	17.91	-1.92	Upgrade
Issuance of Common Stock	31.17	40.4	43.13	9	43.21	Upgrade
Other Financing Activities	-0.61	-4.68	-	-1.57	-1.79	Upgrade
Financing Cash Flow	50.69	35.29	41.86	25.35	39.51	Upgrade
Foreign Exchange Rate Adjustments	9.52	-3.65	1.5	-0.45	-0.06	Upgrade
Net Cash Flow	0.95	-4.07	2.01	-8.06	7.47	Upgrade
Free Cash Flow	-59.26	-35.7	-41.35	-32.96	-30.22	Upgrade
Free Cash Flow Margin	-2163.60%	-226.42%	-3044.85%	-481.35%	-236.14%	Upgrade
Free Cash Flow Per Share	-0.85	-0.67	-1.49	-4.21	-4.88	Upgrade
Cash Interest Paid	11.42	2.99	3.59	2.09	0.8	Upgrade
Levered Free Cash Flow	-14.96	-34.96	-23.22	-19.52	-27.22	Upgrade
Unlevered Free Cash Flow	-7.06	-34.69	-22.67	-18.72	-26.72	Upgrade
Change in Working Capital	-1.16	-12.31	-0.28	5.54	-3.8	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.